Eran Rotem
Deputy CEO and CFO · CollPlant Biotechnologies Ltd
Individual
- 2026
- Sep 8, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Eran Rotem's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Matthew Rabinowitz - $142.28M in NTRA purchases and sales in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eran Rotem?
Eran Rotem is a corporate insider, tracked as Deputy CEO and CFO of CollPlant Biotechnologies Ltd (CLGN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Eran Rotem submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
